Pharma Mar, S.A. (PHM.VI)
Pharma Mar, S.A., a biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
79.45-0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+0.6%
The outlook
Pharma Mar, S.A. currently reads as leaning bearish based on below its 50- & 200-day averages, 34% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range34% of the way from its 52-week low to high
Market cap
$1.38B
52-wk high
104.80
52-wk low
66.50
50-day avg
81.86
200-day avg
81.98
Trailing P/E
17.2